Cihan Ay

About Cihan Ay

Cihan Ay, With an exceptional h-index of 69 and a recent h-index of 52 (since 2020), a distinguished researcher at Medizinische Universität Wien, specializes in the field of Haemostasis, Thrombosis, Anticoagulation, Bleeding disorders, Haemophilia.

His recent articles reflect a diverse array of research interests and contributions to the field:

Incidence and outcomes of bleeding events in patients with cancer: results from a prospective cohort study

Age-related differences in the presentation, management, and clinical outcomes of 100,000 patients with venous thromboembolism in the RIETE registry

Thromboembolism and bleeding in newly diagnosed Multiple Myeloma–Rates, risk profile and patterns of thromboprophylaxis

Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K …

Impact of thrombosis location on walking capacity: a cohort study of patients with acute deep vein thrombosis

Platelet glycoprotein IIb-and IIIa levels are altered in persistently lupus anticoagulant positive patients with a history of thrombosis

Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review

Correspondence to: Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the …

Cihan Ay Information

University

Position

Austria

Citations(all)

17219

Citations(since 2020)

11580

Cited By

8915

hIndex(all)

69

hIndex(since 2020)

52

i10Index(all)

228

i10Index(since 2020)

204

Email

University Profile Page

Google Scholar

Cihan Ay Skills & Research Interests

Haemostasis

Thrombosis

Anticoagulation

Bleeding disorders

Haemophilia

Top articles of Cihan Ay

Incidence and outcomes of bleeding events in patients with cancer: results from a prospective cohort study

Hämostaseologie

2024/2

Age-related differences in the presentation, management, and clinical outcomes of 100,000 patients with venous thromboembolism in the RIETE registry

Archivos de Bronconeumología

2024/1/3

Thromboembolism and bleeding in newly diagnosed Multiple Myeloma–Rates, risk profile and patterns of thromboprophylaxis

Hämostaseologie

2024/2

Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K …

Research and Practice in Thrombosis and Haemostasis

2024/1/1

Daniel Steiner
Daniel Steiner

H-Index: 4

Cihan Ay
Cihan Ay

H-Index: 41

Impact of thrombosis location on walking capacity: a cohort study of patients with acute deep vein thrombosis

Research and Practice in Thrombosis and Haemostasis

2024/1/1

Platelet glycoprotein IIb-and IIIa levels are altered in persistently lupus anticoagulant positive patients with a history of thrombosis

Hämostaseologie

2024/2

Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review

2024/1

Cihan Ay
Cihan Ay

H-Index: 41

Correspondence to: Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the …

Annals of Oncology

2024

A Machine Learning Approach to Identify Patients at Risk for Long-Term Consequences after Pulmonary Embolism

Hämostaseologie

2024/2

Telomere length is associated with increased risk of bleeding in patients on hemodialysis

Hämostaseologie

2024/2

Growth differentiation factor-15 is associated with bleeding risk in patients with cancer: results from a prospective cohort

European Heart Journal

2023/11

Platelet function analyzer (PFA-100) in patients with bleeding disorder of unknown cause

Hämostaseologie

2024/2

Anxiety and quality of life in the acute and post-acute phase after venous thromboembolism

Hämostaseologie

2024/2

Association of telomere length, a marker of biological aging, with hemophilia severity

Hämostaseologie

2024/2

Functional limitations three and twelve months after venous thromboembolism: Results from a prospective cohort study

Hämostaseologie

2024/2

Plasmin generation and fibrinolysis in adults with primary immune thrombocytopenia

Hämostaseologie

2024/2

Combined effects of clonal hematopoiesis and carotid stenosis on cardiovascular mortality

Journal of the American College of Cardiology

2024/5/7

Cihan Ay
Cihan Ay

H-Index: 41

Robert Kralovics
Robert Kralovics

H-Index: 40

High risk of thromboembolic events in adult with primary immune thrombocytopenia: results from a prospective cohort study

Hämostaseologie

2024/2

Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer

Thrombosis Research

2024/5/1

Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry

Journal of the American Geriatrics Society

2024/1

See List of Professors in Cihan Ay University(Medizinische Universität Wien)

Co-Authors

academic-engine